Then
Conventional Practice
- Treatment based on population averages
- Diagnose disease after symptoms appear
- Pharmacogenomics guesswork — trial and error medication
- Reactive: manage what’s already broken
For Clinicians, Hospitals, and Healthcare Leaders
Know first. Treat better.
Precision genomics, pharmacogenomics, and clinical testing. Built into your practice. Not bolted on.
Schedule a partnership conversationTreatment is not the same as knowledge.
Most of medicine is reactive. A patient walks in with symptoms. We diagnose. We treat. We hope.
Precision medicine inverts that. Genetics tells us who is at risk five, ten, fifteen years before symptoms. Pharmacogenomics tells us which drug at which dose will work for this patient. Risk scoring tells us which preventive protocols are worth their time and ours.
The doctors who practise this way today will define Indian healthcare a decade from now.
We don’t treat populations. We treat people. One person at a time.
From averages to individuals.
Medicine is moving from one-size-fits-all to one-of-one. The practices that adopt precision early will define the next decade. The rest will catch up — slower, and from behind.
Now
Precision Practice
- Treatment calibrated to individual genomics
- Identify risk decades before symptoms
- Pharmacogenomics-informed prescribing — right drug, right dose
- Predictive: prevent what’s coming
Your Patients
What This Means For Them
- 5–10 year early detection window
- Significantly fewer adverse drug reactions
- Personalised lifestyle and treatment protocols
- Confidence — they know their plan is built for them
Patients are already choosing.
Indian families travelling abroad for genomic testing. Senior executives flying to Singapore, Bangkok, Boston for precision medicine consultations. Younger patients walking into clinics already knowing more about their genetics than their doctor.
The patient population is moving faster than the practice. The clinicians who close that gap will define the next decade of Indian medicine. The rest will spend the decade catching up.
5,000+
Indians already tested with WinDNA
200+
Medications with established pharmacogenomic guidelines
78%
Of global genomic data is European-origin — not calibrated for South Asians
Six panels. One partnership.
From hereditary cancer to pharmacogenomics. NABL-accredited, calibrated for South Asian biology.
Whole Genome Sequencing
Comprehensive 30x WGS for high-resolution analysis of all ~3 billion base pairs. The deepest view of your patient’s genome.
Whole Exome Sequencing
Targeted sequencing of all protein-coding regions — where ~85% of disease-causing mutations occur. High clinical yield, balanced cost.
Pharmacogenomics
DNA-guided drug selection across 200+ medications. Reduce adverse reactions, optimise dosing, eliminate trial-and-error prescribing.
Cancer Genomics
Somatic and germline panels for solid tumours and haematologic malignancies. Targeted therapy selection, recurrence monitoring, treatment matching.
Hereditary Disease Panels
BRCA1/2, Lynch syndrome, cardiac, neurological, and 100+ hereditary panels. Risk stratification for proactive care across families.
Preventive Genomics
Polygenic risk scores for diabetes, cardiovascular disease, and metabolic syndrome — calibrated to South Asian populations. Wellness reports your patients act on.
Built into your practice. Not bolted on.
-
Onboarding
60-minute clinical orientation with the WinDNA medical affairs team. We map your patient profile, set up your account, and align reporting.
-
Co-Branded Reports
Every report your patients receive carries your clinic’s identity alongside ours. Your brand, our science.
-
Clinician Dashboard
Track every patient’s results, recommendations, and follow-ups through a HIPAA-aligned dashboard. Built for clinical workflow.
-
Continuing Support
Monthly clinical case reviews, CME-aligned training, and direct access to genetic counsellors when you need interpretation help.
More than a lab. A clinical partner.
South Asian Reference Data
Most genomic databases are 78% European. WinDNA reference data is calibrated to Indian and South Asian populations — so risk scores actually fit your patients.
Clinical Interpretation Support
Every report is reviewed by certified clinicians and genetic counsellors. You don’t have to interpret variants alone.
CME-Aligned Training
Quarterly CME modules in clinical genomics, pharmacogenomics, and precision medicine. Continuing education built into the partnership.
Co-Branded Patient Materials
Reports, follow-up letters, and patient education — all co-branded with your clinic. Your patients see your name on the science.
Sample-to-Report Logistics
Kit dispatch, sample collection support, courier pickup, and lab routing all handled by us. Your front desk doesn’t manage logistics — they hand the kit to the patient and we take it from there.
DPDP Act Compliant Infrastructure
All patient data stays India-resident, encrypted at rest and in transit. Compliant with DPDP Act 2023 from day one.
Built on evidence. Replicated across cohorts.
85%
of disease-causing variants live in protein-coding regions — captured by WES
200+
medications with established pharmacogenomic guidelines covered in our PGx panels
30%
of patients carry a clinically actionable pharmacogenomic variant
Selected Publications
- Whole genome sequencing for clinical decision support — Nature Reviews Genetics, 2023
- South Asian polygenic risk score calibration — Nature Communications, 2024
- Pharmacogenomic implementation in clinical practice — Lancet Digital Health, 2024
A growing network of India’s most forward clinicians.
Across cardiology, oncology, internal medicine, endocrinology, and family practice — clinicians who refuse to wait for medicine to catch up.
Mumbai
Bangalore
Delhi
Pune
Chennai
Hyderabad
Kolkata
Ahmedabad
Sambalpur University
AIC-RMP Mumbai
NABL Accredited Lab Network
DPDP Aligned
ISO 15189 Certified
What partner clinicians tell us.
“For the first time, I have pharmacogenomic data on my patients before I prescribe. The reduction in adverse drug events is measurable — and the patient confidence is remarkable.”
Internal Medicine · Mumbai partner clinic
“Co-branded reports change the patient relationship. My patients see precision medicine being delivered through my practice — not by a lab they’ve never heard of.”
Family Medicine · Bangalore partner clinic
“The clinical interpretation support is what made adoption possible. I’m not interpreting raw variants alone — there’s always a counsellor I can call.”
Oncology · Pune partner clinic
Transparent. Volume-based. Direct.
Volume-based pricing
Your pricing scales with your practice. The more patients you refer, the lower your per-test cost. No setup fees. No annual minimums. We earn the partnership month by month.
Dedicated medical affairs
Every partner clinic has a single point of contact for clinical queries, sample logistics, and report interpretation. No call centres. No ticket queues.
Transparent reporting
Your dashboard shows every patient’s test status, turnaround time, and pending follow-ups in real time. We don’t hide the operational layer.
Pricing is discussed in the partnership conversation, not on a public page. Every clinic’s volume and panel mix is different.
What clinicians ask before they partner.
The practical questions every clinician we’ve onboarded has wanted answered first.
How does WinDNA fit into my existing clinical workflow?
We integrate at the touchpoints you already have. Sample collection happens at your clinic or via patient self-collection kit. Reports arrive both as a co-branded clinical PDF for the patient file and as structured data through our HIPAA-aligned dashboard. Most partner clinics are operational within two weeks of onboarding.
How quickly can we begin ordering tests after onboarding?
Within 14 days. Onboarding includes a 60-minute clinical orientation with our medical affairs team, account setup, co-branded report template alignment, and your first sample collection kits dispatched. Your first test orders can be placed the day kits arrive.
How accurate are the results? What is the validation pipeline?
Every test runs through NABL-accredited lab partners operating to ISO 15189 quality standards. Variant calling follows ACMG guidelines, with manual curation by certified clinical geneticists for any variant of uncertain significance. Pharmacogenomic interpretation follows CPIC guidelines. Every report passes through a clinical geneticist before release — no unreviewed AI output reaches your patient.
What clinical interpretation support do I get?
Every partner clinic has direct access to our clinical genomics team — board-certified clinical geneticists and genetic counsellors. You can call, WhatsApp, or email when you need help interpreting a specific patient’s variant in clinical context. No ticket queues, no support portals.
Will reports work with my EMR system?
Reports are delivered as both a clinical PDF (for patient files) and as structured data via our dashboard. For practices using major EMRs (Practo, eClinicalWorks, custom systems), we offer HL7-formatted data export. Direct EMR integration is available for partner clinics above a defined volume threshold — we’ll discuss this during onboarding.
Do I receive CME credits for the training modules?
Yes. Quarterly CME modules in clinical genomics, pharmacogenomics, and precision medicine are accredited through partner institutions. Active partner clinicians typically earn 8–12 CME credit hours per year through the partnership.
How is patient data handled? Where does it live?
All patient data — sequencing data, reports, clinical metadata — stays India-resident, encrypted at rest and in transit. We are DPDP Act 2023 compliant by design, not retrofit. Patient data is never sold, never shared with insurers, never used for marketing. Your patients’ genetic information is theirs alone.
How do I get started with a partnership conversation?
WhatsApp our medical affairs team directly using the button below, or email partners@windna.in. The first conversation is 30 minutes. We discuss your patient population, your panel mix preferences, your operational fit, and your questions. No obligation. No sales script. Just a clinical conversation about whether the partnership fits.
Begin
The doctors who lead medicine tomorrow. Began today.
A 30-minute partnership conversation will tell you whether WinDNA is the right fit for your practice. No obligation. No sales script. Just a clinical conversation.
Know first. Treat better.